Phospholipase A2 (LP-PLA2) antibody and antigen (hapten, BSA/OVA conjugated)
Diagnostic anti-Phospholipase A2 (LP-PLA2) antibodies (anti-Phospholipase A2, anti-LP-PLA2) and diagnostic hapten-carrier conjugates BSA-Phospholipase A2 (LP-PLA2), OVA-Phospholipase A2 (LP-PLA2), KLH-Phospholipase A2 (LP-PLA2) antigens for Metabolic diseases LP-PLA2 detection in ELISA test, competitive ELISA, Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.
Go to Neurodegenerative diseases diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-SMT-LP-PLA2-Ag01 | BSA-Phospholipase A2 (LP-PLA2) | 756 |
GMP-SMT-LP-PLA2-Ag02 | OVA-Phospholipase A2 (LP-PLA2) | 756 |
GMP-SMT-LP-PLA2-Ab01 | Anti-human Phospholipase A2 (LP-PLA2) mouse monoclonal antibody (mAb) | 1953 |
GMP-SMT-LP-PLA2-Ab02 | Anti-human Phospholipase A2 (LP-PLA2) human monoclonal antibody (mAb) | 1953 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. of Products | GMP-SMT-LP-PLA2-Ag01 |
Product Name | BSA-Phospholipase A2 (LP-PLA2) |
Target/Biomarker | Phospholipase A2 (LP-PLA2) |
Expression platform | Synthetic |
Isotypes | NA |
Bioactivity validation | Phospholipase A2 (LP-PLA2) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in LP-PLA2 level test of Metabolic diseases (atherosclerosis, hyperlipidemia, obesity, and diabetes) and related syndrome evaluation. |
Tag | NA |
Products description | Competitive immunoassay-validated hapten-carrier conjugates BSA-Phospholipase A2 (LP-PLA2) / OVA-Phospholipase A2 (LP-PLA2) is Synthetic. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-SMT-LP-PLA2-Ag02 |
Product Name | OVA-Phospholipase A2 (LP-PLA2) |
Target/Biomarker | Phospholipase A2 (LP-PLA2) |
Expression platform | Synthetic |
Isotypes | NA |
Bioactivity validation | Phospholipase A2 (LP-PLA2) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in LP-PLA2 level test of Metabolic diseases (atherosclerosis, hyperlipidemia, obesity, and diabetes) and related syndrome evaluation. |
Tag | NA |
Products description | Competitive immunoassay-validated hapten-carrier conjugates BSA-Phospholipase A2 (LP-PLA2) / OVA-Phospholipase A2 (LP-PLA2) is Synthetic. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-SMT-LP-PLA2-Ab01 |
Product Name | Anti-human Phospholipase A2 (LP-PLA2) mouse monoclonal antibody (mAb) |
Target/Biomarker | Phospholipase A2 (LP-PLA2) |
Expression platform | Hybridoma |
Isotypes | Mouse IgG |
Bioactivity validation | Phospholipase A2 (LP-PLA2) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in LP-PLA2 level test of Metabolic diseases (atherosclerosis, hyperlipidemia, obesity, and diabetes) and related syndrome evaluation. |
Tag | mFc |
Products description | Competitive immunoassay-validated hapten-carrier conjugates BSA-Phospholipase A2 (LP-PLA2) / OVA-Phospholipase A2 (LP-PLA2) is Synthetic. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Competitive immunoassay validation (Competitive ELISA),Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-SMT-LP-PLA2-Ab02 |
Product Name | Anti-human Phospholipase A2 (LP-PLA2) human monoclonal antibody (mAb) |
Target/Biomarker | Phospholipase A2 (LP-PLA2) |
Expression platform | Hybridoma |
Isotypes | Mouse IgG |
Bioactivity validation | Phospholipase A2 (LP-PLA2) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in LP-PLA2 level test of Metabolic diseases (atherosclerosis, hyperlipidemia, obesity, and diabetes) and related syndrome evaluation. |
Tag | mFc |
Products description | Competitive immunoassay-validated hapten-carrier conjugates BSA-Phospholipase A2 (LP-PLA2) / OVA-Phospholipase A2 (LP-PLA2) is Synthetic. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Competitive immunoassay validation (Competitive ELISA),Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
The phospholipase A2 (PLA2) family of proteins includes lipolytic enzymes that catalyze the hydrolysis of the ester bond at the sn-2 position of phospholipids to yield free fatty acids and lysophospholipids. Each member of the phospholipase A2 family of enzymes serves a distinct role in generating active lipid metabolites that promote inflammatory metabolic diseases including atherosclerosis, hyperlipidemia, obesity, and diabetes.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments
No comments yet.